Showing results (141-150 of 167) with videos related to
Sort By:
Pageof 17
Cardiovascular Research|March 15, 2008
Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failureJulie H Rennison, Tracy A McElfresh, Isidore C Okere, et al.Journal of Cell Science|February 10, 2023
DRP1 mutations associated with EMPF1 encephalopathy alter mitochondrial membrane potential and metabolic programsGabriella L Robertson, Stellan Riffle, Mira Patel, et al.Protein Science : a Publication of the Protein Society|December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closureKenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.Journal of Medicinal Chemistry|October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinasesZhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.Chembiochem : a European Journal of Chemical Biology|January 10, 2018
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure SurrogateRussell A Judge, Anil Vasudevan, Victoria E Scott, et al.Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitorsLe Wang, Gary T Wang, Xilu Wang, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.Journal of Computer-Aided Molecular Design|February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discoveryKent D Stewart, Kevin Steffy, Kevin Harris, et al.Biochemistry|June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitorsKenton L Longenecker, Kent D Stewart, David J Madar, et al.Pageof 17